AnaSpec Introduces Thirty-Six New Catalog Peptides

PRLog (Press Release) – Feb 12, 2008 – This week AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced thirty-six (36) new catalog peptides.

Beta-Amyloid (1-40) Binding Peptide - Cat# 62426
Beta-Amyloid (1-40) Binding Peptide, biotinylated - Cat# 62427
Beta-Amyloid (1-20) - Cat# 62456
Biotin-LC-beta-Amyloid (1-16) - Cat# 62458
Biotin-beta-Amyloid (1-15) - Cat# 62461
Beta-Amyloid(15-26)-Lys(Biotin)-NH2 - Cat# 62469
Beta-Amyloid (11-28)-Lys (Biotin)-NH2 - Cat# 62472
Beta-Amyloid (1-40), DAC-labeled - Cat# 61949-01
Innate Defense Regulator-1 (IDR-1) - Cat# 62514
Mundticin KS - Cat# 61917-05
NOXA BH3, Peptide 2 - Cat# 62403
PUMA BH3 - Cat# 62404
BAD (CT-1) - Cat# 62271
Bad (103-127), human, all d-isomers - Cat# 62322
BH3 BIM Peptide (52-71), human - Cat# 62439
HB-1 (26-41) - Cat# 62511
BAFF-R (160-183) - Cat# 62523
Alpha B-Crystallin (73-92) - Cat# 62411
TAT-NSF700 Fusion Peptide - Cat# 62238
Lipid Membrane Translocating Peptide - Cat# 62397
Leptin (57-74) - Cat# 62521
Insulin Growth Factor Binding Protein 6 (IGFBP6 ), mouse - Cat# 62418
Link N - Cat# 62518
HIV-1, Envelope Glycoprotein (187-203) - Cat# 62435
Preptin, Human Pro-Insulin Growth Factor II (69-80), human - Cat# 62430
Apolipoprotein J (215-222) - Cat# 62516
Apolipoprotein L (306-316) - Cat# 62517
epsilon-V1-2, epsilon-PKC Inhibitor, Cys-conjugated - Cat# 62187
TRBP, Thyroid Hormone (TR)-binding Protein, biotinylated - Cat# 62287
ERK 1/2 /MAP Kinase Substrate, FAM labeled - Cat# 62342
Glycogen Synthase Kinase 3 alpha (GSK3a) (16-26), phosphorylated - Cat# 62354
Dominant H2-Kd Ligand - Cat# 62510
Inter-alpha-trypsin inhibitor heavy chain 4, C-terminal fragment (H4CT) - Cat# 62252
Eukaryotic Translation Initiation Factor,4E b - Cat# 62372
Measles Virus Fusion Protein (288-302) - Cat# 62408
Influenza Virus Nucleoprotein (277-286) - Cat# 62422

Company Info
AnaSpec, Inc. is a leading provider of integrated proteomics solutions to pharmaceutical, biotech, and academic research institutions throughout the world. With a vision for innovation through synergy, AnaSpec focuses on three core technologies: peptides, detection reagents, and combinatorial chemistry. Established in 1993, AnaSpec's headquarters and manufacturing facilities are located in San Jose, CA.

For more information visit www.anaspec.com